Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
International Journal of Molecular Sciences|June 19, 2024
Preclinical Evaluation of Biodistribution and Toxicity of [<sup>211</sup>At]PSMA-5 in Mice and Primates for the Targeted Alpha Therapy against Prostate CancerTadashi Watabe, Kazuko Kaneda-Nakashima, Yuichiro Kadonaga, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 12, 2023
Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with <sup>89</sup>Zr or <sup>211</sup>At: A Theranostic Approach for Pancreatic Ductal AdenocarcinomaTadashi Watabe, Kazuya Kabayama, Sadahiro Naka, et al.International Journal of Molecular Sciences|November 27, 2024
Comparison Length of Linker in Compound for Nuclear Medicine Targeting Fibroblast Activation Protein as Molecular TargetKentaro Hisada, Kazuko Kaneda-Nakashima, Yoshifumi Shirakami, et al.Journal of Medicinal Chemistry|October 28, 2021
Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High <i>In Vivo</i> StabilityHiroyuki Suzuki, Yuta Kaizuka, Maho Tatsuta, et al.Cancer Science|December 5, 2020
α-Emitting cancer therapy using <sup>211</sup> At-AAMT targeting LAT1Kazuko Kaneda-Nakashima, ZiJian Zhang, Yoshiyuki Manabe, et al.Inorganic Chemistry|October 15, 2013
Measurement of the Md3+/Md2+ reduction potential studied with flow electrolytic chromatographyAtsushi Toyoshima, Zijie Li, Masato Asai, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 25, 2025
First-in-Human Study of [<sup>211</sup>At]NaAt as Targeted α-Therapy in Patients with Radioiodine-Refractory Thyroid Cancer (Alpha-T1 Trial)Tadashi Watabe, Kosuke Mukai, Sadahiro Naka, et al.Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Evaluation of <sup>64</sup>Cu-Labeled New Anti-EGFR Antibody NCAB001 with Intraperitoneal Injection for Early PET Diagnosis of Pancreatic Cancer in Orthotopic Tumor-Xenografted Mice and Nonhuman PrimatesHiroki Matsumoto, Tadashi Watabe, Chika Igarashi, et al.International Journal of Molecular Sciences|November 9, 2024
Evaluation of Targeted Alpha Therapy Using [<sup>211</sup>At]FAPI1 in Triple-Negative Breast Cancer Xenograft ModelsKaori Abe, Tadashi Watabe, Kazuko Kaneda-Nakashima, et al.International Journal of Molecular Sciences|May 27, 2023
Evaluation of Astatine-211-Labeled Fibroblast Activation Protein Inhibitor (FAPI): Comparison of Different Linkers with Polyethylene Glycol and PiperazineAyaka Aso, Hinako Nabetani, Yoshifumi Matsuura, et al.Pageof 5